Oral corticosteroid reduction and discontinuation in adults with corticosteroid-dependent, severe, uncontrolled asthma treated with tezepelumab (WAYFINDER): a multicentre, single-arm, phase 3b trial
Authors
Mark Gurnell
Guy Brusselle (ORCID: https://orcid.org/0000-0001-7021-8505)
Ricardo del Olmo (ORCID: https://orcid.org/0000-0002-8375-1939)
Nanna Keeling
Liam Gabriel Heaney (ORCID: https://orcid.org/0000-0002-9176-5564)
Neil A. Martin (ORCID: https://orcid.org/0000-0002-6565-4131)
Oral corticosteroid reduction and discontinuation in adults with corticosteroid-dependent, severe, uncontrolled asthma treated with tezepelumab (WAYFINDER): a multicentre, single-arm, phase 3b trial
Mark Gurnell, Guy Brusselle, Ricardo del Olmo, Nanna Keeling et al.
Citations
4 citations
Journal
The Lancet Respiratory Medicine
Topics
Asthma and respiratory diseases
Field-Weighted Citation Impact (FWCI)
4.66
article
Oral corticosteroid reduction and discontinuation in adults with corticosteroid-dependent, severe, uncontrolled asthma treated with tezepelumab (WAYFINDER): a multicentre, single-arm, phase 3b trial
Mark Gurnell, Guy Brusselle, Ricardo del Olmo, Nanna Keeling, Liam Gabriel Heaney, Neil A. Martin, Njira Lucia Lugogo, Robert Fogel, Kinga Sałapa, Stephanie Korn, Amit Parulekar, Pascal Chanez, David J. Jackson, Shamir Chandarana, Jean‐Pierre Llanos, Konstantinos Kostikas, Bill Cook
article en
4 citations
Abstract
No abstract available for this paper.
Publication Tag
The Lancet Respiratory MedicineVol. 14(2)
Institutions
AstraZeneca (United Kingdom) (GB), Queen's University Belfast (GB), Guy's Hospital (GB), Amgen (United States) (US), King's College London (GB), University of Ioannina (GR), Aix-Marseille Université (FR), University of Michigan (US), Ghent University Hospital (BE), National Institute for Health and Care Research (GB), Instituto de Diagnóstico e Investigaciones Metabólicas (AR), Frauenklinik Heidelberg (DE), AstraZeneca (Poland) (PL), AstraZeneca (Finland) (FI), AstraZeneca (Italy) (IT), AstraZeneca (United States) (US), NIHR Leicester Biomedical Research Centre (GB)